ArticleScientific reports2025
The efficacy of C1/2 arthrodesis with C2 root resection at symptomatic side for occipital neuralgia from atlantoaxial osteoarthritis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article aimed to assess the efficacy of surgical treatments, particularly arthrodesis with C2 nerve transection, in patients with atlantoaxial osteoarthritis (AAOA). Data of patients with AAOA who underwent surgical treatment between January 2020 and November 2023 were retrospectively collected. Of 11 patients with AAOA, nine underwent fusion surgery, and two underwent decompression surgery. C2 root transection on the symptomatic side was performed in all fusion cases. C2 root transection was not performed during decompression. All patients experienced immediate and persistent pain relief after surgery. Four patients who underwent fusion surgery reported a complete disappearance of pain. Four patients who underwent fusion surgery reported some numbness of the scalp, but it did not affect the quality of daily activities or cause significant discomfort. One patient who underwent decompression surgery reported residual tingling sensation and hyperesthesia of the scalp. We concluded that C1-2 fusion surgery is an excellent surgical treatment option and should be primarily considered for patients with refractory AAOA. C2 root transection on the symptomatic side can completely alleviate pain at the expense of minor scalp anesthesia. Decompressive-only surgery is not recommended but can be considered in strictly selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.